Spherix completes $20M equity financing round

NewsGuard 100/100 Score

Spherix Incorporated (NASDAQ: SPEX), an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that it has completed a $20 million equity financing consisting of 10 million shares of Series J Convertible Preferred Stock (convertible into common stock) at $2 per share to raise gross proceeds of $20 million, before payment of placement agent fees and other expenses of the offering payable by us. No warrants were issued as part of the transaction.

Anthony Hayes, Chief Executive Officer of Spherix, stated, "This closing is another major step in the evolution of Spherix into a world-class monetization company. We believe the confidence expressed by these investors in Spherix substantiates our belief in the value of our intellectual property and the future of the company. We believe that this transaction provides Spherix with the necessary funding to meet our contractual obligations to Rockstar Consortium US LP for the remainder of 2014 and to help fund the company's growth." 

The transaction was closed on June 2, 2014, pursuant to Spherix's effective shelf registration previously filed with the Securities and Exchange Commission on Form S-3, dated May 7, 2014, as supplemented by a preliminary and final prospectus supplement and the public filings incorporated by reference therein.  Laidlaw & Company (UK) Ltd. acted as the placement agent for the transaction.

Source:

Spherix Incorporated

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.